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Abstract: The current global crisis of antimicrobial resistance (AMR) among important human
bacterial pathogens has been amplified by an increased resistance prevalence. In recent years,
a number of studies have reported higher resistance levels among Listeria monocytogenes isolates,
which may have implications for treatment of listeriosis infection where resistance to key treatment
antimicrobials is noted. This study examined the genotypic and phenotypic AMR patterns of 100
L. monocytogenes isolates originating from food production supplies in Australia and examined this in
the context of global population trends. Low levels of resistance were noted to ciprofloxacin (2%) and
erythromycin (1%); however, no resistance was observed to penicillin G or tetracycline. Resistance to
ciprofloxacin was associated with a mutation in the fepR gene in one isolate; however, no genetic
basis for resistance in the other isolate was identified. Resistance to erythromycin was correlated
with the presence of the ermB resistance gene. Both resistant isolates belonged to clonal complex
1 (CC1), and analysis of these in the context of global CC1 isolates suggested that they were more
similar to isolates from India rather than the other CC1 isolates included in this study. This study
provides baseline AMR data for L. monocytogenes isolated in Australia, identifies key genetic markers
underlying this resistance, and highlights the need for global molecular surveillance of resistance
patterns to maintain control over the potential dissemination of AMR isolates.
Keywords: Listeria monocytogenes; antimicrobial resistance; single-nucleotide polymorphism
subtyping; ermB; fepR; Australia
1. Introduction
Listeria monocytogenes is a foodborne pathogen and the causative agent of the human infection,
listeriosis. L. monocytogenes is widely distributed throughout the environment and has been isolated
throughout the various stages of the food production and supply chain [1,2]. Incidences of listeriosis
are frequently associated with the consumption of raw or ready-to-eat foodstuffs—processed meats,
soft cheese, milk products, salad, and seafood [3]. Although rare, invasive listeriosis has a high
fatality rate of 20–30% [4]. It is characterised by invasion of the central nervous system, blood,
or placenta, causing symptoms such as meningitis, encephalitis, and septicaemia [5]. Those with
increased susceptibility include the immunocompromised, elderly, pregnant women, and newborn
children. L. monocytogenes is of additional concern to pregnant women as it has the ability to translocate
into the placenta causing perinatal infection, miscarriage, and stillbirth [6,7].
Listeriosis has traditionally been treatable using a combination of a β-lactam antibiotic,
such as amoxicillin, penicillin, or ampicillin, and an aminoglycoside, such as gentamycin [8].
Successful treatment with trimetroprim-sulfamethoxazole has been used to treat patients with an
allergy to the reference treatment of penicillin, and tetracycline and erythromycin have been used
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as an alternative treatment option, including treatment of patients not responding to standard
therapy [9,10]. Although L. monocytogenes is inherently resistant to some antibiotics—primarily
cephalosporins, oxacillin, and fosfomycin—it has historically been susceptible to most antibiotics
used to treat Gram-positive bacteria [11,12]. Interestingly, successful use of fosfomycin for ocular
infections, which typically shows little activity in vitro, is thought to be due to the low-glucose
environment [13]. However, there have been a series of reports of L. monocytogenes isolates resistant
to one or more antibiotics, particularly in Southern and Western regions of Asia, which have serious
associated public health implications [14–17].
Manifestation of antibiotic resistance has been decisively linked to the increased selective
pressure caused by the extensive use of antibiotics as a growth promoter in livestock animals or
in medical treatment of humans or animals [18]. The primary cellular mechanisms of resistance
include active transport of the antibiotic out of the bacterial cell via efflux pumps, reduced cell
membrane permeability, modification of the antibiotic target site, or inactivation of the antibiotic
through enzymatic degradation [19].
The genetic basis of fluoroquinolone resistance in L. monocytogenes has been previously linked
to overexpression of the genes lde, encoding an efflux pump of the major facilitator superfamily,
and fepA, of the multidrug and toxic compound extrusion (MATE) family, which are universally
found in L. monocytogenes [20]. Mutation to the quinolone resistance-determining regions (QRDR) of
the genes encoding for DNA gyrase topoisomerase II (gyrA, gyrB) and topoisomerase IV (parC and
parE) has also been reported to confer resistance to fluoroquinolones in Gram-positive bacteria [21].
Studies of L. monocytogenes by Lampidis et al. (2002) and Moreno et al. (2014) reported mutations
in the QRDR region of gyrA resulting in amino acid changes—Thr84Ser, Phe88Asp/Phe88Glu,
and Met117Ser/Met117Gly—associated with fluoroquinolone resistance [22,23].
Erythromycin resistance determinants, erm genes, encode for a ribosome methylase that
methylates an adenine residue in the 23S portion of the 50S ribosomal subunit [24]. erm genes
identified in L. monocytogenes (ermA, ermB, and ermC) have also been associated with mobile
genetic elements, principally plasmid pAMβ1 and pIP501 originating in Enterococcus faecalis
and Streptococci agalactiae, respectively [25]. L. monocytogenes has been observed to encode a
plasmid-mediated trimethoprim-resistant dihydrofolate reductase (DHFR) [26]. Plasmid pIP823,
carrying resistant DHFR gene dfrD, can be transferred by conjugative mobilisation between
L. monocytogenes, Staphylococci spp., and Escherichia coli.
Tetracycline resistance in L. monocytogenes has been linked to mobile genetic elements carrying the
tetracycline resistance genes tetA, tetK, and tetL, which confer proton antiporter efflux pump proteins,
as well as tetM and tetS, conferring ribosomal protection proteins [8,27]. The most common determinant
for tetracycline resistance, tetM, has been found in Tn916/Tn1545-like conjugative transposons first
discovered in E. faecalis [28,29]. Poyart-Salmeron et al. (1992) identified tetM and int-Tn, an integrase
required for conjugation of the Tn916/Tn1545-like transposon, in 24 of 33 L. monocytogenes isolates
resistant to tetracycline [30]. An additional tetracycline-resistant isolate in this study harboured
plasmid pIP813, also believed to have originated in Enterococci and Streptococci spp., which carried the
tetL gene. The presence of the mobile genetic elements originating from unrelated bacterial species
suggests that both Gram-negative and Gram-positive bacteria may have a significant role in resistance
gene acquisition by L. monocytogenes [31].
To the authors’ knowledge, this is the first study to evaluate antibiotic sensitivities of
L. monocytogenes isolated from food sources in Australia and investigated the prevalence of genetic
markers associated with antimicrobial resistance (AMR) to antibiotics including the genetic basis for
resistance phenotypes observed. This study characterised 100 L. monocytogenes isolates from Australian
food production chains to establish a baseline that can be used for further AMR surveillance relating
to this important human pathogen.
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2. Materials and Methods
2.1. Bacterial Strains
A total of 100 L. monocytogenes samples encompassing isolates from dairy products (n = 52),
meat products (n = 42), vegetables (n = 2), food (n = 2), dairy farm environment (n = 1), and seafood
(n = 1) were recovered from Australian food production chains between 1988 and 2016. An additional
72 clonal complex 1 isolates (CC1) were included in the phylogenetic analysis of this subgroup, as
defined in the standard scheme [32]. A complete list of isolates is presented in Supplementary Table S1.
2.2. Serotyping of PCR Serogrouping of Isolates
Isolates were differentiated by serotype using a combination of O-antigen antisera testing
(Denka Seiken Co., Ltd., Tokyo, Japan) and multiplex PCR serogrouping [33].
2.3. Pulsed-Field Gel Electrophoresis Subtyping
Molecular subtyping of the isolates was performed using the PulseNet standard method for
L. monocytogenes [34]. Similarity analysis of ApaI and AscI restriction profiles was performed using
BioNumerics software, v7.6 (Applied Maths, Sint-Martens-Latem, Belgium). Restriction enzyme
fingerprints were analysed using the Unweighted Pair Group Method with Arithmetic Mean,
Dice correlation coefficient, and a tolerance and optimisation margin of 1%. Indistinguishable isolates
were defined as those that demonstrated no band differences from each other.
2.4. Antibiotic Susceptibility Testing
The sensitivity of all 100 isolates in this study to a panel of four antibiotics was determined,
comprising ciprofloxacin (0.002–32 µg/mL), erythromycin (0.016–256 µg/mL), penicillin G
(0.002–32 µg/mL), and tetracycline (0.016–256 µg/mL). Penicillin G and other β-lactam antibiotics
are the foremost treatment option for L. monocytogenes infection [35]. Ciprofloxacin, a fluoroquinolone
antibiotic, has been used to treat listeriosis with associated meningitis, although questions have been
raised regarding its suitability [36]. Erythromycin, a macrolide antibiotic, and tetracycline, a polyketide,
have been traditionally used as a treatment option for L. monocytogenes in the case of β-lactam
allergy [35]. The Minimum Inhibitory Concentration (MIC) of each antimicrobial was quantitated using
Oxoid M.I.C.Evaluator™ strips (Oxoid, Basingstoke, UK) on Mueller-Hinton agar plates supplemented
with 5% sheep blood (Oxoid), according to the manufacturer’s instructions. Mueller-Hinton agar
plates were inoculated with a bacterial solution suspension in 3 mL of Maximum Recovery Diluent
adjusted to the turbidity of a 0.5 McFarland. The inoculated plates were incubated at 37 ◦C for 48 h.
Control strains used were Staphylococcus aureus ATCC 29213 and Streptococcus pneumoniae ATCC 49619.
The MIC values were interpreted using the Clinical and Laboratory Standards Institute (CLSI) or
European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoint guidelines for
L. monocytogenes where available, and Staphylococci spp. [37,38].
2.5. Whole Genome Sequencing and Multilocus Sequence Typing
Draft genomes for each isolate were subjected to bioinformatic analyses. Draft genomes were
prepared as previously described [39]. Gene BLAST searches and alignments of L. monocytogenes
isolates tested in this study were performed using the Geneious software platform v10.0.7 [40].
Multilocus Sequence Typing (MLST) STs were determined by examining the gene sequence of seven
housekeeping genes, using primers and gene targets previously described [32]. Isolates included
representatives of major L. monocytogenes sequence types (STs) previously reported circulating in
Australia, such as ST1, ST2, ST3, ST155, and ST204 [41]. A list of AMR genes used in BLAST searches
is presented in Table S2.
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2.6. Phylogenetic Analysis of Clonal Complex 1 Isolates
The single-nucleotide polymorphism (SNP) phylogeny was determined with kSNP v3.1 [42] for 79
isolates using a mixture of finished genomes, draft genomes, and read data. Paired-end read files were
quality filtered, converted to fasta and merged using seqtk v1.2–r102 (https://github.com/lh3/seqtk).
The core phylogeny was determined using a Kmer setting of 21 as determined with the Kchooser
program in kSNP v3.1.
3. Results
3.1. Serotyping
L. monocytogenes may be classified into genetic lineages [43]. O-antigen antiserum combined
with multiplex PCR serotyping identified that 56 isolates were of genetic lineage II (1/2a, 3a, 1/2c,
and 3c); the majority were associated with serotype 1/2a (n = 48), followed by serotype 1/2c (n = 4),
and serotype 3a (n = 4). Forty-three isolates were determined to be of Lineage I (1/2b, 3b, 7, 4b, 4d,
and 4e); the majority were identified as serotype 1/2b (n = 30), followed by 4b (n = 8), 3b (n = 3), and 4d
(n = 2). Only one Lineage III isolate was identified, which was serotype 4a.
3.2. Pulsed-Field Gel Electrophoresis Subtyping
Analysis of the combined ApaI and AscI identified 78 unique pulsotypes (Figure 1). Isolates were
clustered into the three groups which related to Lineage I, Lineage II, and Lineages III/IV.
3.3. Antimicrobial Resistance Characteristics
The MIC distribution of the isolates to the panel of four antibiotics is shown in Figure 2.
Susceptibility was defined as a MIC value of ≤1 mg/L for ciprofloxacin (EUCAST S. aureus breakpoint,
as no L. monocytogenes breakpoint is defined), ≤1 mg/L for erythromycin (EUCAST breakpoint),
≤2 mg/L for penicillin G (CLSI breakpoint), and ≤4 mg/L for tetracycline (CLSI S. aureus breakpoint,
as no L. monocytogenes breakpoint is defined). All isolates were found to be susceptible to penicillin G
and tetracycline. Two serotype 4b isolates were resistant to ciprofloxacin only (2948 and Lm16-001,
MIC of 2 mg/L and 4 mg/L, respectively); isolate Lm16-001 was also resistant to erythromycin
(MIC > 256 mg/L).
3.4. Detection of Genetic Markers Related to Antimicrobial Resistance
All isolates were found to harbour the fosfomycin resistance gene, fosX, and the lincomycin
resistance gene, lmrB. An analysis of the QRDR regions of gyrA, gyrB, parC, and parE genes revealed no
mutations responsible for fluoroquinolone resistance. There were no tetracycline (tetA, tetK, tetL, tetM
and tetS), trimethoprim (dfrD and dfrG), or vancomycin (vanA and vanB) resistance-associated genes
identified. No mobile genetic elements containing antibiotic resistance determinants were detected.
Interrogation of erythromycin resistance determinants (ermA, ermB, and ermC) identified a single
resistance gene, ermB, harboured by isolate Lm16-001. This correlated with the phenotypic observation
of erythromycin resistance of this isolate (>256 mg/L).
When comparing the genome of ciprofloxacin-resistant (CipR) isolate 2948 to wild-type (WT)
isolates, a single-point mutation was identified in the fluoroquinolone efflux protein (fepA) regulator,
fepR (Figure 3). The mutation, located at nucleotide position 181, resulted in a premature stop codon
(PMSC) in place of amino acid aspartic acid (E61*). Analysis of the fepR gene in the other ciprofloxacin
resistant isolate (Lm16-001) did not identify a mutation at this position, with this isolate encoding a
full length fepR protein. However, a unique single-point mutation at nucleotide position 170 caused an
amino acid change from alanine to glycine. Further investigation is required to determine if this has a
role in the CipR phenotype of Lm16-001.
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Figure 3. Comparison of a full-length wild-type fepR protein with the truncated fepR protein identified
in this study and that of Guerin et al. 2014 [20] conferring resistance to ciprofloxacin.
3.5. Clonal Complex 1 Population Structure Analysis
Clonal complexes are groups of closely related STs which share sequence homology among at least
six alleles. Further analysis was performed on a larger set of CC1 isolates to understand the phylogeny
of the CC1 isolates in this study with a set of isolates from other global r gions. Analysis of the CC1
genomes (Figure 4) showed antimicrobial resistant isolat s in this stu y clustered together, and were
separate from this study’s other CC1 isolates. Expanding the analysis to include additional CC1 isolates
showed both AMR isolates (2948 and Lm16-001) to be more closely related to three isolates from India
(BHU1, BHU2, and BHU3; clade A in Figure 4) than to other CC1 isolates (including both other CC1
isolates from this study and other CC1 isolates from other global regions). Analysis of isolates in clade
A identified a ciprofloxacin genotype and/or phenotype, suggesting that a ciprofloxacin resistance
phenotype is associated with this small subgroup of L. monocytogenes within CC1, although it should be
noted the majority of CC1 isolates in this analysis did not contain the ciprofloxacin resistance marker.
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Figure 4. Phylogenetic analysis of clonal complex 1 (CC1) genomes, showing a parsimony tree
generated by kSNP using a core single-nucleotide polymorphism (SNP) alignment. Box A: clade
containing both AMR isolates identified in this study, and three other ST328 isolates from India. With
the exception of Lm16-001, isolates in this clade had a mutation leading to a premature stop codon
(PMSC) in their respec ive fepR genes. Genotype: CipR, PMSC in the fepR gene and/or phenotypically
demonstrated resistance (+); ermB, presence (+) or absence (−).
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4. Discussion
Modern years have seen the dynamics of food production and supply shift from locally grown
and consumed foods to a globally connected food supply paradigm [44]. This presents new challenges
to the control of foodborne pathogens and has implications for their ecology. The capacity for strains of
L. monocytogenes to colonise and persist in localised environments has been extensively reported [45–47],
and, as such, globalised food chains present new vectors for L. monocytogenes distribution to other
geographical niches. These new vectors present new opportunities for opportunistic colonisation of
new niches across the globe, and, as such, present a new challenge to maintaining food safety.
Until recent years, studies on antibiotic resistance of L. monocytogenes cohorts have typically
reported low levels of resistance; however, recent studies, including studies of isolates from Asia and
the Middle East, have reported an emerging prevalence of AMR among L. monocytogenes isolated
from those regions (Table 1). Other studies including temporal analysis of isolates from the same
geographical region suggest an increasing trend in L. monocytogenes AMR, although, importantly,
this resistance has not typically been to the key treatment choices for listeriosis infection [48,49].
This may have implications for public health in these regions regarding treatment of listeriosis,
should resistance to key treatments evolve and expand, but more broadly has implications for
dissemination of AMR isolates across the globe through contaminated food carriage since this
represents the primary vector for human transmission [50].
Table 1. Previous studies documenting antimicrobial resistance (AMR) among Listeria monocytogenes
isolate cohorts.
Location CollectionStart Date
Sample
Size
Ciprofloxacin
(% Resistant)
Erythromycin
(% Resistant)
Penicillin
(% Resistant)
Tetracycline
(% Resistant) Study
Brazil 1978 26 7.1 0 0 0 [22]
France 1989 4668 0.43 0.02 NT a 0.7 [48]
Brazil 2003 50 0 6 0 2 [51]
China 2005 90 17.8 2.22 1.11 15.6 [15]
USA 2005 157 3 0 0 3 [52]
Switzerland 2006 383 7 0 0 1.3 [29]
Ireland 2007 191 0 0 4 1 [53]
Italy 2008 120 1.7 0 0 0.8 [54]
USA 2009 90 2 0 0 1 [55]
Ireland 2011 51 0 0 0 0 [1]
Iran 2012 43 NT 14 16.3 27.9 [56]
Ethiopia 2012 24 NT NT 66.7 37.5 [57]
Indonesia 2012 29 0 6.9 17.2 0 [17]
China 2013 78 0 1.3 1.3 20.5 [58]
Colombia 2013 259 7.4 15.8 0 6.6 [59]
Turkey 2014 12 0 NT 66.7 0 [60]
India 2014 5 0 NT 100 20 [61]
Yemen 2015 51 NT 58.8 100 56.8 [62]
India 2015 21 NT 85.7 100 90.5 [62]
Egypt 2015 32 NT 62.5 93.8 59.4 [62]
a NT, Not tested.
The findings of this study suggest that the overall levels of antibiotic resistance among
L. monocytogenes isolates from food production systems in Australia is relatively low. Despite this,
emerging reports of resistant strains of L. monocytogenes to reference or alternative antibiotic treatments
could present a public health risk due to the high mortality rate of this human pathogen. To this end,
further investigation of the molecular ecology of resistant isolates can not only yield insights into the
geographical distribution of these resistant isolates, but also provide valuable baseline data to build
an ongoing surveillance platform to monitor AMR among target species such as L. monocytogenes.
This analysis can also identify key resistance markers which contribute to this resistance, and examine
their implications for dissemination through the population. While genetic mutations such as SNPs
giving rise to a resistance phenotype do not necessarily have serious implications for transfer through
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the bacterial population, the occurrence of resistance markers on transferrable mobile genetic elements
such as transposons or plasmids may have significant implications for dissemination of resistance.
This study found no isolates that were resistant to penicillin G or tetracycline. A single isolate was
resistant to erythromycin. Increased rates of resistance to erythromycin have been reported in Indonesia
(6.9%), Iran (14%), Yemen (58.8%), Egypt (62.5%), and India (85.7%) [17,33,57]. The erythromycin
resistant isolate in this study harboured the ermB gene, and displayed high resistance to the antibiotic
(>256 mg/L). MLST subtyping identified this isolate as an ST1 isolate; however, this isolate showed
closer genotypic homology to ST328 isolates than to other ST1 isolates in this analysis (Figure 1).
It should be noted that both ST1 and ST328 are closely related members of the L. monocytogenes CC1.
Similar clustering results were observed when additional CC1 isolates were included in a phylogenetic
analysis (Figure 4); additional CC1 isolates from other global regions will provide greater insight
into the evolution of CC1. Isolates from the ST328 subgroup are among the most prevalent of both
clinical and food isolates in India. While this dataset does not include epidemiological information
relating to the foods from which these strains were isolated, nonetheless, ongoing surveillance of
import and export foods clearly has a place in food safety programs. Indeed, the debate regarding use
of antibiotics and associated regulations in food animals is ongoing [63], and, as such, understanding
food contamination and transmission of key pathogens is becoming an increasingly important facet of
food safety protocol. It is worth noting that the high prevalence of AMR noted by Obaidat et al. (2015)
was among L. monocytogenes from export foods, again highlighting this emerging food safety issue [34].
Resistance to ciprofloxacin was identified in only 2% (n = 2) of isolates in this study. Reports of
ciprofloxacin resistance in L. monocytogenes have been consistently low with the exception of a study in
China that observed a frequency of 17.8% [15]. Ciprofloxacin is not traditionally used as a treatment
option in cases of listeriosis. As such, the prevalence of resistant strains in this study is not of critical
significance in the context of current treatment courses from a public health perspective. A SNP
mutation (G61T) in the fluoroquinolone efflux pump repressor gene, fepR, was previously identified as
the mechanism of ciprofloxacin resistance in a clinical L. monocytogenes isolate [20].
Through the construction of a deletion mutant in a WT L. monocytogenes strain, the researchers
were able to confirm the role of fepR as a transcriptional repressor of fepA and observed a 32-fold
increase in MIC value to ciprofloxacin in the deletion mutant. A similar mutation was identified in
the ciprofloxacin-resistant isolate 2948 in this study. However, the mutation found in strain 2948 in
this study (G181T) was located 120 bp downstream of that described in the previous study (Figure 3).
Restoration of the full-length fepR gene is nonetheless required to confirm its role in the cirpfloxacin
phenotype of isolate 2948. The fepR gene of Lm16-001, in contrast, was identified as a full-length
genotype. In addition, no mutations known to impart AMR were identified in the gyrA or parC genes
of Lm16-001. As such, further study is needed to identify the underlying mechanism for ciprofloxacin
resistance in this isolate.
The high similarity evidenced by the PFGE profiles of isolates 2948 and Lm16-001 suggested
that they may be genetically similar. Combined PFGE and MLST analysis indicated that the resistant
isolate Lm16-001 was ST1 and more closely related to the ST328 resistant isolate, rather than the
other ST1 isolates in this study; this observation underlies the need for increased datasets including
additional CC1 isolates to provide a stronger understanding of the true distribution of CC1 clones
across Australasia and, indeed, globally. Both isolates belong to serotype 4b, which causes the majority
of human listeriosis cases [50]. Interestingly, L. monocytogenes MLST type ST328 is rarely isolated in
Australia, where ST1, ST3, and ST204 dominate [40,42]. MLST type ST328 is highly abundant among
strains isolated in India [64]. Further analysis of CC1 isolates from different global regions showed
both resistant isolates in this study clustered closely with the isolates from India (clade A, Figure 4).
Although data is limited, some studies of L. monocytogenes isolated from India have reported high
frequencies of resistance to penicillin (100%), tetracycline (90.5%), and erythromycin (85.7%) [33,62].
Also concerning is the finding of vancomycin resistance (57.7%) among isolates, as this antibiotic is
considered a last line of defense against multidrug-resistant Gram-positive bacteria [65]. Further work
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is required to understand if these emerging reports of AMR are more widely distributed across the
L. monocytogenes population or limited to the subsets of isolates in the associated studies. All isolates in
clade A demonstrated genotypic (contained a PMSC in their fepR genes) or phenotypic ciprofloxacin
resistance, suggesting that the isolates from India in this clade may also be phenotypically ciprofloxacin
resistant; however, it should be noted that data in this study does not suggest that ciprofloxacin
resistance is widely distributed among CC1 isolates.
5. Conclusions
There currently exists insufficient breakpoint documentation required for MIC interpretation,
impeding standardised 4ave established breakpoints for ampicillin, benzylpenicillin, erythromycin,
meropenem, penicillin, and Trimethoprim-sulfamethoxazole only [54,55]. Furthermore, there is a
lack of empirical data in Australia on AMR in foodborne L. monocytogenes in order to establish the
significance of the resistance levels reported in this study. Further surveillance in Australia of the
prevalence of AMR in this important human pathogen is recommended; however, this study provides
a basis for further investigation. National antimicrobial stewardship of food animals is an important
aspect of the One Health approach to control AMR [66]. Findings of this study support the need for a
global context approach to AMR surveillance of food chains. National AMR surveillance programs
must not rely solely on breakpoint data, but should include population analysis through molecular
subtyping to monitor resistant subpopulations and potential emerging resistant subgroups. In addition,
the role of food imports and exports on the dissemination of AMR requires consideration.
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